FGF21 Is Released During Increased Lipogenesis State Following Rapid-Onset Radioiodine-Induced Hypothyroidism

BACKGROUND: FGF21 pharmacological treatment reverses fatty liver and lowers serum triglyceride concentration but FGF21 serum level is increased in hepatic steatosis. FGF21 secretion is induced by thyroid hormones in vitro. PURPOSE: To determine the influence of thyroid hormones and metabolic changes...

Descripción completa

Detalles Bibliográficos
Autores principales: Szczepańska, Ewa, Glinicki, Piotr, Zgliczyński, Wojciech, Słowińska-Srzednicka, Jadwiga, Jastrzębska, Helena, Gietka-Czernel, Małgorzata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329662/
https://www.ncbi.nlm.nih.gov/pubmed/35909532
http://dx.doi.org/10.3389/fendo.2022.900034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329662/
https://www.ncbi.nlm.nih.gov/pubmed/35909532
http://dx.doi.org/10.3389/fendo.2022.900034

Ejemplares similares